Abbott To Acquire Exact Sciences For Up To $23B
Abbott (ABT) on Thursday said that it has entered into a definitive agreement to acquire Exact Sciences (EXAS) for up to $23 billion.
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. The transaction is expected to close in the second quarter of 2026, subject to the receipt of necessary approvals.
The transaction was unanimously approved by both companies' boards of directors, the companies said.
Get updates to this developing story directly on Stocktwits.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment